Fer Kinase Regulates Cell Migration Through α-dystroglycan Glycosylation

Overview

Journal Mol Biol Cell

Specialties Cell Biology
Molecular Biology

Date 2012 Jan 13

PMID 22238358

Citations 15

Authors

Tohru Yoneyama

Kiyohiko Angata

Xingfeng Bao

Sara Courtneidge

Sumit K Chanda

Minoru Fukuda

Affiliations

Soon will be listed here.

Abstract

Glycans of α-dystroglycan (α-DG), which is expressed at the epithelial cell-basement membrane (BM) interface, play an essential role in epithelium development and tissue organization. Laminin-binding glycans on α-DG expressed on cancer cells suppress tumor progression by attenuating tumor cell migration from the BM. However, mechanisms controlling laminin-binding glycan expression are not known. Here, we used small interfering RNA (siRNA) library screening and identified Fer kinase, a non-receptor-type tyrosine kinase, as a key regulator of laminin-binding glycan expression. Fer overexpression decreased laminin-binding glycan expression, whereas siRNA-mediated down-regulation of Fer kinase increased glycan expression on breast and prostate cancer cell lines. Loss of Fer kinase function via siRNA or mutagenesis increased transcription levels of glycosyltransferases, including protein O-mannosyltransferase 1, β3-N-acetylglucosaminyltransferase 1, and like-acetylglucosaminyltransferase that are required to synthesize laminin-binding glycans. Consistently, inhibition of Fer expression decreased cell migration in the presence of laminin fragment. Fer kinase regulated STAT3 phosphorylation and consequent activation, whereas knockdown of STAT3 increased laminin-binding glycan expression on cancer cells. These results indicate that the Fer pathway negatively controls expression of genes required to synthesize laminin-binding glycans, thus impairing BM attachment and increasing tumor cell migration.

Citing Articles

Fer and FerT Govern Mitochondrial Susceptibility to Metformin and Hypoxic Stress in Colon and Lung Carcinoma Cells.

Marciano O, Mehazri L, Shpungin S, Varvak A, Zacksenhaus E, Nir U Cells. 2021; 10(1).

PMID: 33430475 PMC: 7826929. DOI: 10.3390/cells10010097.

The dystroglycan receptor maintains glioma stem cells in the vascular niche.

Day B, Lathia J, Bruce Z, DSouza R, Baumgartner U, Ensbey K Acta Neuropathol. 2019; 138(6):1033-1052.

PMID: 31463571 PMC: 6851226. DOI: 10.1007/s00401-019-02069-x.

FER promotes cell migration via regulating JNK activity.

Li P, Ma Z, Yu Y, Hu X, Zhou Y, Song H Cell Prolif. 2019; 52(5):e12656.

PMID: 31264309 PMC: 6797522. DOI: 10.1111/cpr.12656.

Targeting FER Kinase Inhibits Melanoma Growth and Metastasis.

Ivanova I, Arulanantham S, Barr K, Cepeda M, Parkins K, Hamilton A Cancers (Basel). 2019; 11(3).

PMID: 30909648 PMC: 6468679. DOI: 10.3390/cancers11030419.

Stanicka J, Rieger L, OShea S, Cox O, Coleman M, OFlanagan C Oncogene. 2018; 37(23):3131-3150.

PMID: 29540831 DOI: 10.1038/s41388-017-0113-z.

References

Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Nomura Y, Segawa M . An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature. 1998; 394(6691):388-92. DOI: 10.1038/28653. View

Peyrard M, Seroussi E, Sandberg-Nordqvist A, Xie Y, Han F, Fransson I . The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. Proc Natl Acad Sci U S A. 1999; 96(2):598-603. PMC: 15182. DOI: 10.1073/pnas.96.2.598. View

Ding L, Getz G, Wheeler D, Mardis E, McLellan M, Cibulskis K . Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008; 455(7216):1069-75. PMC: 2694412. DOI: 10.1038/nature07423. View

Pasder O, Shpungin S, Salem Y, Makovsky A, Vilchick S, Michaeli S . Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells. Oncogene. 2006; 25(30):4194-206. DOI: 10.1038/sj.onc.1209695. View

Polyak K, Weinberg R . Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009; 9(4):265-73. DOI: 10.1038/nrc2620. View

Larsen M, Artym V, Green J, Yamada K . The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol. 2006; 18(5):463-71. DOI: 10.1016/j.ceb.2006.08.009. View

White D, Kurpios N, Zuo D, Hassell J, Blaess S, Mueller U . Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell. 2004; 6(2):159-70. DOI: 10.1016/j.ccr.2004.06.025. View

Barresi R, Campbell K . Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci. 2006; 119(Pt 2):199-207. DOI: 10.1242/jcs.02814. View

Fukuda A, Wang S, Morris 4th J, Folias A, Liou A, Kim G . Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell. 2011; 19(4):441-55. PMC: 3075548. DOI: 10.1016/j.ccr.2011.03.002. View

10.

Brockington M, Blake D, Prandini P, Brown S, Torelli S, Benson M . Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet. 2001; 69(6):1198-209. PMC: 1235559. DOI: 10.1086/324412. View

11.

Ferletta M, Kikkawa Y, Yu H, Talts J, Durbeej M, Sonnenberg A . Opposing roles of integrin alpha6Abeta1 and dystroglycan in laminin-mediated extracellular signal-regulated kinase activation. Mol Biol Cell. 2003; 14(5):2088-103. PMC: 165099. DOI: 10.1091/mbc.e03-01-0852. View

12.

Craig A, Zirngibl R, Williams K, Cole L, Greer P . Mice devoid of fer protein-tyrosine kinase activity are viable and fertile but display reduced cortactin phosphorylation. Mol Cell Biol. 2001; 21(2):603-13. PMC: 86629. DOI: 10.1128/MCB.21.2.603-613.2001. View

13.

Levayer R, Lecuit T . Breaking down EMT. Nat Cell Biol. 2008; 10(7):757-9. DOI: 10.1038/ncb0708-757. View

14.

Greer P . Closing in on the biological functions of Fps/Fes and Fer. Nat Rev Mol Cell Biol. 2002; 3(4):278-89. DOI: 10.1038/nrm783. View

15.

El Sayegh T, Arora P, Fan L, Laschinger C, Greer P, McCulloch C . Phosphorylation of N-cadherin-associated cortactin by Fer kinase regulates N-cadherin mobility and intercellular adhesion strength. Mol Biol Cell. 2005; 16(12):5514-27. PMC: 1289398. DOI: 10.1091/mbc.e05-05-0410. View

16.

Shimojo H, Kobayashi M, Kamigaito T, Shimojo Y, Fukuda M, Nakayama J . Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer. Prostate. 2011; 71(11):1151-7. PMC: 3174275. DOI: 10.1002/pros.21330. View

17.

Grady R, Grange R, Lau K, Maimone M, Nichol M, Stull J . Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol. 1999; 1(4):215-20. DOI: 10.1038/12034. View

18.

Spence H, Dhillon A, James M, Winder S . Dystroglycan, a scaffold for the ERK-MAP kinase cascade. EMBO Rep. 2004; 5(5):484-9. PMC: 1299052. DOI: 10.1038/sj.embor.7400140. View

19.

Zoubeidi A, Rocha J, Zouanat F, Hamel L, Scarlata E, Aprikian A . The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth. Mol Cancer Res. 2009; 7(1):142-55. DOI: 10.1158/1541-7786.MCR-08-0117. View

20.

Bromberg J, Wrzeszczynska M, Devgan G, Zhao Y, Pestell R, Albanese C . Stat3 as an oncogene. Cell. 1999; 98(3):295-303. DOI: 10.1016/s0092-8674(00)81959-5. View